Literature DB >> 25369601

Controversies regarding the use of antithrombin for sepsis-associated disseminated intravascular coagulation: an update of the evidence.

Toshiaki Iba1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25369601      PMCID： PMC4317106          DOI： 10.2450/2014.0164-14

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  5 in total

Review 1.  Clinical use and the Italian demand for antithrombin.

Authors:  Giancarlo M Liumbruno; Massimo Franchini; Monica Lanzoni; Fabio Candura; Stefania Vaglio; Samantha Profili; Liviana Catalano; Giuseppina Facco; Simonetta Pupella; Gabriele Calizzani; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 2.  Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan.

Authors:  T Iba; S Gando; J Thachil
Journal:  J Thromb Haemost       Date:  2014-06-19       Impact factor: 5.824

3.  Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines.

Authors:  H Wada; J Thachil; M Di Nisio; P Mathew; S Kurosawa; S Gando; H K Kim; J D Nielsen; C-E Dempfle; M Levi; C-H Toh
Journal:  J Thromb Haemost       Date:  2013-02-04       Impact factor: 5.824

4.  Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.

Authors:  T Tagami; H Matsui; H Horiguchi; K Fushimi; H Yasunaga
Journal:  J Thromb Haemost       Date:  2014-07-16       Impact factor: 5.824

5.  A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.

Authors:  Satoshi Gando; Daizoh Saitoh; Hiroyasu Ishikura; Masashi Ueyama; Yasuhiro Otomo; Shigeto Oda; Shigeki Kushimoto; Katsuhisa Tanjoh; Toshihiko Mayumi; Toshiaki Ikeda; Toshiaki Iba; Yutaka Eguchi; Kohji Okamoto; Hiroshi Ogura; Kazuhide Koseki; Yuichiro Sakamoto; Yasuhiro Takayama; Kunihiro Shirai; Osamu Takasu; Yoshiaki Inoue; Kunihiro Mashiko; Takaya Tsubota; Shigeatsu Endo
Journal:  Crit Care       Date:  2013-12-16       Impact factor: 9.097
  5 in total
  1 in total

Review 1.  Hemostatic abnormalities in critically ill patients.

Authors:  Marcel Levi; Suthesh Sivapalaratnam
Journal:  Intern Emerg Med       Date:  2014-12-24       Impact factor: 3.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.